基本信息
views: 418
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Raymond Stevens课题组在糖尿病、肥胖等人类重大疾病相关的G蛋白偶联受体(GPCR)结构生物学及功能研究领域取得多项重大成就(Science, 2020; Nature Communication, 2020; Nature, 2017)。近年来,课题组靶向血糖调控中发挥关键作用的胰岛β细胞,通过跨时-空尺度生物成像手段,打通原子、分子、细胞、组织、活体研究的界限,深入开展生理及病理情况下胰岛β细胞的动态功能研究(部分研究成果发表于Science Advances, 2020a; Science Advances, 2020b; Proc Natl Acad Sci U S A., 2022),为糖尿病等重要代谢类疾病的下一代医疗奠定研究基础。
Raymond Stevens亦积极开展转化研究,其研发的上市药物包括:Nesina, Kuvan, Pegvilase, Zeposia, Botox。
Raymond Stevens亦积极开展转化研究,其研发的上市药物包括:Nesina, Kuvan, Pegvilase, Zeposia, Botox。
Research Interests
Papers共 765 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yi-Fan Zeng,Ke-Xin Yang, Yilong Cui,Xiao-Na Zhu, Rui Li, Hanqing Zhang,Dong Chuan Wu,Raymond C. Stevens,Ji Hu,Ning Zhou
NATURE COMMUNICATIONSno. 1 (2024): 3221-3221
Weimin Li,Angdi Li, Bing Yu, Xiaoxiao Zhang, Xiaoyan Liu,Kate L. White,Raymond C. Stevens,Wolfgang Baumeister,Andrej Sali,Marion Jasnin,Liping Sun
ACS central scienceno. 5 (2023): 992-1007
crossref(2023)
ACS CENTRAL SCIENCEno. 5 (2023): 992-1007
Ye Xin, Shuo Liu,Yan Liu, Zhen Qian,Hongyue Liu,Bingjie Zhang,Taijie Guo,Garth J Thompson,Raymond C Stevens,K Barry Sharpless,Jiajia Dong,Wenqing Shui
Proceedings of the National Academy of Sciences of the United States of Americano. 11 (2023)
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAno. 19 (2023)
Cited3Views0Bibtex
3
0
Yang Yang,Hye Jin Kang,Ruogu Gao,Jingjing Wang,Gye Won Han,Jeffrey F. DiBerto,Lijie Wu,Jiahui Tong,Lu Qu,Yiran Wu, Ryan Pileski, Xuemei Li,
NATURE COMMUNICATIONSno. 1 (2023): 1692-1692
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 725
#Citation: 68497
H-Index: 125
G-Index: 251
Sociability: 8
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn